SciTech Development
SciTech Development provides pharmaceuticals comprising nanoparticle fenretinide formulation with immunotherapy benefits, as well as a patented nanoparticle delivery technology, allowing physicians to treat their patients with effective and advanced therapies.
$2.73M
Funding
Venture Fund
Stage
7
Employees
United States
Location
Funding Details
Amount: $2.73M
Type: Venture Fund
Date: 2023-06-08
Location & Size
City & State: Grosse Pointe Farms, Michigan
Country: United States
Employee Count: 7
Similar Investors
Amplexd Therapeutics
Amplexd Therapeutics focuses on the development of non-invasive, topical treatments aimed at addressing HPV-induced cervical dysplasia, a precursor to cervical cancer. The company's mission centers on providing accessible solutions to combat this public health issue, offering alternatives to the traditional 'watch and wait' approachfor low-grade cases.
4P-Pharma
4P-Pharma specializes in the development of therapeutics that offer treatment for osteoarthritis with analgesic and anti-inflammatory properties.
Clock.bio
Clock.bio aims to extend and improve quality of life by reversing the harmful effects of time in our cells, harnessing the regenerative capabilities of human pluripotent stem cells.
Vertex Ventures HC
Vertex Ventures HC makes investments in a range of healthcare-related fields, including as biopharmaceuticals, medical technology, and digital health. Their portfolio includes businesses in every stage of development, from start-ups exploring game-changing technology to mature businesses looking to expand.